Home  >  TopNews
you can get e-magazine links on WhatsApp.Click here
Pioma_Lactic
Research + Font Resize -

CSIR-CCMB conducting research on three different methods for developing corona vaccine

A Raju, Hyderabad
Saturday, October 24, 2020, 08:00 Hrs  [IST]

The authorities of Centre for Scientific and Industrial Research-Centre for Cellular and Molecular Biology (CSIR-CCMB) have revealed that lead scientists are conducting in-depth studies to develop three new different methodologies for developing an effective and long lasting immune booster vaccine for the deadly coronavirus.

According to Dr Rakesh Mishra, director of CCMB, it cannot be certainly told when the corona vaccine will come to the market for the public use. As there are more than 8 different leading companies trying their best to bring out their respective vaccines for the COVID-19 disease across the world, majority of them have cleared the first and second phase clinical studies and are expected to get into the third phase trials in the coming days. Meanwhile, the people will have to be cautious and make sure they follow the COVID-19 safety norms of using face masks, gloves and hand sanitizers to stay safe from being infected.

“As majority vaccine candidates are undergoing various stages of clinical trials, it cannot be told certainly when will be most effective and affordable vaccine will be launched in the markets for the use of common public. Even though if all the ongoing clinical trials complete in the coming 6 months and the vaccine is launched, it cannot be assured how long will be the vaccine effective. There is a possibility of continuation of research on the vaccine candidate for its efficacy and efficiency even after 6 months of its launch, because, one cannot ascertain its effectiveness unless and until we get a clear picture of its research data on its safety and effectiveness for the next one year. Therefore, even if the vaccine is launched one cannot say that the society will be free of corona infection and people need to continue to use food items which boost their immunity regularly and must follow COVID-19 safety norms to stay free from contracting the deadly virus,” Dr Mishra opined.
 
As Bharat Biotech, Serum institute, Dr Reddy’s Laboratories and other pharma and biotech companies have already started their research and got approvals from the Drug Control General of India (DGCI) for conducting clinical trials in India, the CCMB director hoped that in the next 6 months the vaccine may be available for the public. However, he also did not hesitate to say that there are also possibilities of failures of vaccine candidates at any stage and therefore there is no guarantee if these companies will come out with an effective vaccine. Until then he advised the people to live with caution and urged them to wear masks, adopt hand sanitization habit and maintain social distancing to stay safe from the deadly virus.

Dr Mishra later launched a new novel nutraceutical food supplement called ‘Corona Aid’ developed by a new start-up company called Clone Deals. According to Mishra, this new food supplement was developed at its Atal Incubation centre in CCMB. This food supplement is said to be very rich an immune booster component like anti-oxidants and can effectively prevent humans from being infected with the virus.

“Corona Aid food supplement is made from a mushroom (cordyceps militaris) that grows in Himalayan region and is known for its immune boosting and anti-oxidant components. At present the food supplement is undergoing clinical trials and the final product is expected to be available in the market from December this year,” informed the CCMB director.

 

*POST YOUR COMMENT
Comments
* Name :     
* Email :    
  Website :  
   
     
 
 
 
Copyright © 2016 Saffron Media Pvt. Ltd |